Ginkgo Bioworks Holdings Inc vs Plug Power Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13.41 (market cap $763.64M), while Plug Power Inc trades at $1.73 (market cap $2.42B). The key difference: Plug Power Inc is far larger — about 3.2× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Plug Power Inc for 41 Days on average.
| DNA | PLUG | |
|---|---|---|
Market Cap | $763.64M | $2.42B |
Volume | 3,204,177 | 53,851,702 |
Sector | Health | Industrials |
52-Week High | $15.83 | $4.14 |
52-Week Low | $5.48 | $1.73 |
Typical Hold Time | 7 Days | 41 Days |
Enterprise Value | $865.59M | $3.29B |
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $12.84, up 11.94% in the last session. The stock shows a bullish technical signal with strong moving average support, though oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million in 2025 on $170.16 million revenue, with a negative net margin of 219.6%. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting strategic growth initiatives despite financial challenges.
Outlook remains speculative with high risk. The buy/hold/sell analyst split is nearly even, reflecting uncertainty. Significant cash burn and persistent losses pose substantial risks, but partnerships and government contracts offer potential catalysts. Investors should weigh the company's long-term biotechnology prospects against its current lack of profitability and negative cash flow.
Plug Power (PLUG) trades at $1.715, down 3.65% on the day, reflecting ongoing operational challenges despite recent positive developments. The stock shows bearish technical signals with negative moving averages, though oscillators suggest potential oversold conditions. Fundamentally, the company continues to report significant losses with a net income margin of -220.59% and negative cash flow from operations of $535.84 million in 2025. Recent news highlights strategic partnerships including a 280 MW electrolyzer agreement with Arcadia eFuels, providing some optimism for future growth in the green hydrogen sector.
The outlook remains challenging with persistent financial losses and high cash burn, though analyst consensus suggests potential upside with a $3.13 price target. Key risks include execution challenges in scaling hydrogen infrastructure, competitive pressures, and dependence on external financing. Investment opportunity exists for those betting on long-term hydrogen adoption, but requires high risk tolerance given current financial instability and market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →